<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01238016</url>
  </required_header>
  <id_info>
    <org_study_id>H01A03</org_study_id>
    <nct_id>NCT01238016</nct_id>
  </id_info>
  <brief_title>Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot Study</brief_title>
  <acronym>Pilot</acronym>
  <official_title>Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot Study - A One Month Non-controlled Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNEEG Medical A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UNEEG Medical A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial aims at measuring the safety and performance of the Hyposafe device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Safety: To evaluate safety issues related to implantation and use of the Hyposafe&#xD;
      hypoglycaemia alarm device Performance: To evaluate the stability of the hypoglycaemia alarm&#xD;
      device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Replaced by new study&#xD;
  </why_stopped>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device performance</measure>
    <time_frame>End of observation</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Device implant and EEG recording</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>experimental</intervention_name>
    <arm_group_label>device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Healthy control subjects or and&#xD;
&#xD;
          -  Male and female patient with type 1 diabetes for at least one year&#xD;
&#xD;
          -  Age 18-70 years&#xD;
&#xD;
          -  Impaired awareness of hypoglycaemia as defined by&#xD;
&#xD;
               -  A score of â‰¥4 on the Gold-scale or&#xD;
&#xD;
               -  Two or more occasions of severe hypoglycaemia (need of help from third person)&#xD;
                  within the past 12 month&#xD;
&#xD;
          -  Multiple injection insulin therapy or continuous insulin injection therapy&#xD;
&#xD;
          -  For female participants: Not pregnant and, if child bearing potential, usage of&#xD;
             reliable anti-contraceptive method during the study period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiac disease&#xD;
&#xD;
               -  History of myocardial infarction&#xD;
&#xD;
               -  Cardiac arrhythmia&#xD;
&#xD;
          -  Previous stroke or cerebral haemorrhage and any other structural cerebral disease&#xD;
&#xD;
          -  Active cancer or cancer diagnosis within the past five years&#xD;
&#xD;
          -  Uremia defined as s-creatinine above 3 times upper reference value&#xD;
&#xD;
          -  Liver disease defined as s-ALAT above 3 times upper reference interval&#xD;
&#xD;
          -  Inability to understand the informed consent&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Use of antiepileptic drugs for any purposes&#xD;
&#xD;
          -  Clinical important hearing impairment&#xD;
&#xD;
          -  Use of active implantable medical device including&#xD;
&#xD;
               -  Pacemaker and ICD-unit&#xD;
&#xD;
               -  Cochlear implant&#xD;
&#xD;
          -  Use of following drugs&#xD;
&#xD;
               -  Chemotherapeutic drugs of any kind&#xD;
&#xD;
               -  Methotrexate&#xD;
&#xD;
               -  Third generation antipsychotic drugs (aripiprazole, quetiapine, clozapine,&#xD;
                  ziprasidone, paliperidone, risperidone, sertindole, amisulpride, olanzapine)&#xD;
&#xD;
          -  Abuse of alcohol (defined as consumption of &gt; 250g alcohol (in Danish: 21 &quot;genstande&quot;)&#xD;
             per week or abuse of any other neuroactive substances&#xD;
&#xD;
          -  Infection at the site of device-implantation&#xD;
&#xD;
          -  Any hemorrhagic disease&#xD;
&#xD;
          -  Diving (snorkel diving allowed) or parachute jumping&#xD;
&#xD;
          -  Patients that are judged incapable of understanding the patient information or who are&#xD;
             not capable of carrying through the investigation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Esbjerg Sygehus</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2010</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

